Conmed (CNMD) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.80% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.94% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -35.05% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.28% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -4.98% |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn | 42.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.72% |
| Jun 30, 2025 | 647.76% |
| Mar 31, 2025 | -24.59% |
| Mar 31, 2024 | 23.44% |
| Dec 31, 2023 | -29.80% |
| Sep 30, 2023 | 7.12% |
| Jun 30, 2023 | 51.42% |
| Mar 31, 2023 | -3.39% |
| Dec 31, 2022 | -83.04% |
| Jun 30, 2022 | -84.45% |
| Mar 31, 2022 | 14.60% |
| Sep 30, 2021 | -49.04% |
| Mar 31, 2021 | -18.52% |
| Dec 31, 2020 | 24.18% |
| Sep 30, 2020 | -4.25% |
| Jun 30, 2020 | -38.23% |
| Mar 31, 2020 | 62.21% |
| Sep 30, 2019 | -19.46% |
| Mar 31, 2019 | 47.81% |
| Sep 30, 2018 | -39.27% |
| Jun 30, 2018 | -26.75% |
| Mar 31, 2018 | -21.81% |
| Dec 31, 2017 | -29.20% |
| Sep 30, 2017 | 20.79% |
| Jun 30, 2017 | -34.08% |
| Mar 31, 2017 | -27.06% |
| Sep 30, 2016 | -17.43% |
| Mar 31, 2016 | -57.00% |
| Dec 31, 2015 | -30.82% |
| Sep 30, 2015 | -2.04% |
| Jun 30, 2015 | -8.81% |
| Mar 31, 2015 | -14.12% |
| Dec 31, 2014 | 33.86% |
| Sep 30, 2014 | -44.97% |
| Jun 30, 2014 | 1.23% |
| Mar 31, 2014 | 7.40% |
| Dec 31, 2013 | 14.11% |
| Sep 30, 2013 | -9.84% |
| Jun 30, 2013 | 10.69% |